Ascelia Pharma AB: cash_and_equivalents
| Value | {"amount": 21855000.0, "concept": "ifrs-full:CashAndCashEquivalents"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | Ascelia Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:08:51.954826+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/59f9bdd8-a5be-4598-a808-c71b53b9edbe
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:5493002YR9VCJJPWYN08:2024-12-31Retrieved: 2026-08-23T23:08:51.954826+02:00
Raw response sha256:
3618fd33ae161b1e5e0c96fd474d2620…Cite as: FACTANKER, https://factanker.com/fact/59f9bdd8-a5be-4598-a808-c71b53b9edbe
History
- no predecessors — first report